Anna Tavridou
Overview
Explore the profile of Anna Tavridou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tavridou A, Rogers D, Farinelli G, Gravanis I, Jekerle V
Nat Rev Drug Discov
. 2024 Mar;
23(4):242-243.
PMID: 38491159
No abstract available.
2.
Tavridou A, Rogers D, Bonelli M, Schiel A, Hidalgo-Simon A
Br J Clin Pharmacol
. 2020 Nov;
87(6):2459-2464.
PMID: 33237580
Scientific advice (SA) is an important tool offered by regulators to help developers generate robust evidence on a medicine's benefits and risks. Drawing on accumulated experience and looking at the...
3.
Roumeliotis A, Roumeliotis S, Panagoutsos S, Theodoridis M, Argyriou C, Tavridou A, et al.
Ren Fail
. 2019 Mar;
41(1):131-138.
PMID: 30909780
Background: Intima-Media-Thickness of the carotid artery wall (cIMT) is a strong predictor of cardiovascular (CV) disease. The aim of this study was to investigate the significance of cIMT as an...
4.
Giannakopoulou E, Konstantinou F, Ragia G, Gerontitis Z, Tavridou A, Papapetropoulos A, et al.
Drug Metab Pers Ther
. 2019 Mar;
34(1).
PMID: 30860977
Background Cystathionine γ-lyase enzyme, which is encoded by the CTH gene, is responsible for hydrogen sulfide (H2S) production in the endothelium. The CTH 1364 G>T polymorphism may alter the CTH...
5.
Ragia G, Karantza I, Kelli-Kota E, Kolovou V, Kolovou G, Konstantinides S, et al.
Drug Metab Pers Ther
. 2017 Dec;
32(4):183-190.
PMID: 29252193
Background: We have earlier developed a pharmacogenomic algorithm for acenocoumarol dose prediction in Greek patients that included CYP2C9/VKORC1 genetic information. This study aims at analyzing the potential effect of CYP4F2,...
6.
Giannakopoulou E, Konstantinou F, Ragia G, Tavridou A, Karaglani M, Chatzaki E, et al.
OMICS
. 2017 Nov;
21(12):741-748.
PMID: 29173085
Coronary artery disease (CAD) is a major global health burden whereby gene-by-environment-by-sex interactions play an important role. Coronary artery bypass graft (CABG) surgery involves patients with well-documented and severe CAD....
7.
Roumeliotis S, Roumeliotis A, Panagoutsos S, Giannakopoulou E, Papanas N, Manolopoulos V, et al.
J Diabetes Complications
. 2017 Jul;
31(10):1527-1532.
PMID: 28734846
Aims: We sought to determine the predictive value of Matrix Gla Protein MGP T-138C polymorphism in relation to all-cause mortality, cardiovascular mortality and cardiovascular events in patients with diabetic nephropathy...
8.
Ragia G, Kolovou V, Kolovou G, Konstantinides S, Maltezos E, Tavridou A, et al.
Pharmacogenomics
. 2016 Dec;
18(1):23-34.
PMID: 27967328
Aim: To generate and validate a pharmacogenomic-guided (PG) dosing algorithm for acenocoumarol in the Greek population. To compare its performance with other PG algorithms developed for the Greek population. Patients...
9.
Iordanidou M, Paraskakis E, Tavridou A, Chatzimichael A, Manolopoulos V
World J Pediatr
. 2016 Jul;
13(1):34-40.
PMID: 27363984
Background: Childhood asthma phenotype is the consequence of interaction between environment and genetic factors. Nitric oxide (NO) formation is affected by polymorphisms in nitric oxide synthase (NOS) enzymes, which play...
10.
Tavridou A, Georgoulidou A, Roumeliotis A, Roumeliotis S, Giannakopoulou E, Papanas N, et al.
J Diabetes Res
. 2015 Jun;
2015:507265.
PMID: 26064982
Aims: We sought to determine the association between levels of adiponectin and oxidized low-density lipoprotein (ox-LDL) in patients with diabetic nephropathy as well as their effect on carotid intima-media thickness...